• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对接蛋白 p130Cas 调节细胞对蛋白酶体抑制的敏感性。

The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.

机构信息

Cancer Center, Sanford-Burnham Medical Research Institute, 10901 N, Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

BMC Biol. 2011 Oct 28;9:73. doi: 10.1186/1741-7007-9-73.

DOI:10.1186/1741-7007-9-73
PMID:22034875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3215977/
Abstract

BACKGROUND

The focal adhesion protein p130Cas (Cas) activates multiple intracellular signaling pathways upon integrin or growth factor receptor ligation. Full-length Cas frequently promotes cell survival and migration, while its C-terminal fragment (Cas-CT) produced upon intracellular proteolysis is known to induce apoptosis in some circumstances. Here, we have studied the putative role of Cas in regulating cell survival and death pathways upon proteasome inhibition.

RESULTS

We found that Cas-/- mouse embryonic fibroblasts (MEFs), as well as empty vector-transfected Cas-/- MEFs (Cas-/- (EV)) are significantly resistant to cell death induced by proteasome inhibitors, such as MG132 and Bortezomib. As expected, wild-type MEFs (WT) and Cas-/- MEFs reconstituted with full-length Cas (Cas-FL) were sensitive to MG132- and Bortezomib-induced apoptosis that involved activation of a caspase-cascade, including Caspase-8. Cas-CT generation was not required for MG132-induced cell death, since expression of cleavage-resistant Cas mutants effectively increased sensitivity of Cas-/- MEFs to MG132. At the present time, the domains in Cas and the downstream pathways that are required for mediating cell death induced by proteasome inhibitors remain unknown. Interestingly, however, MG132 or Bortezomib treatment resulted in activation of autophagy in cells that lacked Cas, but not in cells that expressed Cas. Furthermore, autophagy was found to play a protective role in Cas-deficient cells, as inhibition of autophagy either by chemical or genetic means enhanced MG132-induced apoptosis in Cas-/- (EV) cells, but not in Cas-FL cells. Lack of Cas also contributed to resistance to the DNA-damaging agent Doxorubicin, which coincided with Doxorubicin-induced autophagy in Cas-/- (EV) cells. Thus, Cas may have a regulatory role in cell death signaling in response to multiple different stimuli. The mechanisms by which Cas inhibits induction of autophagy and affects cell death pathways are currently being investigated.

CONCLUSION

Our study demonstrates that Cas is required for apoptosis that is induced by proteasome inhibition, and potentially by other death stimuli. We additionally show that Cas may promote such apoptosis, at least partially, by inhibiting autophagy. This is the first demonstration of Cas being involved in the regulation of autophagy, adding to the previous findings by others linking focal adhesion components to the process of autophagy.

摘要

背景

黏着斑蛋白 p130Cas(Cas)在整合素或生长因子受体被激活后可激活多种细胞内信号通路。全长 Cas 通常促进细胞存活和迁移,而其在细胞内蛋白水解时产生的 C 端片段(Cas-CT)在某些情况下已知可诱导细胞凋亡。在此,我们研究了 Cas 在蛋白酶体抑制后调节细胞存活和死亡途径中的潜在作用。

结果

我们发现 Cas-/- 小鼠胚胎成纤维细胞(MEFs),以及空载体转染的 Cas-/- MEFs(Cas-/-(EV))对蛋白酶体抑制剂诱导的细胞死亡具有显著抗性,如 MG132 和硼替佐米。正如预期的那样,野生型 MEFs(WT)和用全长 Cas 重建的 Cas-/- MEFs(Cas-FL)对 MG132 和硼替佐米诱导的凋亡敏感,这涉及到半胱天冬酶级联的激活,包括 Caspase-8。MG132 诱导的细胞死亡不依赖于 Cas-CT 的产生,因为表达无切割抗性的 Cas 突变体可有效增加 Cas-/- MEFs 对 MG132 的敏感性。目前,Cas 介导的蛋白酶体抑制剂诱导的细胞死亡所需的结构域和下游途径尚不清楚。有趣的是,然而,MG132 或硼替佐米处理导致 Cas 缺失的细胞中自噬的激活,但在表达 Cas 的细胞中则没有。此外,自噬在 Cas 缺陷细胞中发挥保护作用,因为用化学或遗传方法抑制自噬可增强 Cas-/-(EV)细胞中 MG132 诱导的凋亡,但不能增强 Cas-FL 细胞中的凋亡。Cas 的缺失也导致对 DNA 损伤剂阿霉素的抗性增加,这与 Cas-/-(EV)细胞中阿霉素诱导的自噬一致。因此,Cas 可能在对多种不同刺激的细胞死亡信号转导中具有调节作用。Cas 抑制自噬诱导和影响细胞死亡途径的机制目前正在研究中。

结论

我们的研究表明,Cas 是蛋白酶体抑制诱导的细胞凋亡所必需的,并且可能是由其他死亡刺激引起的。我们还表明,Cas 通过抑制自噬至少部分地促进这种凋亡。这是 Cas 参与自噬调节的首次证明,这增加了之前其他人将黏着斑成分与自噬过程联系起来的发现。

相似文献

1
The docking protein p130Cas regulates cell sensitivity to proteasome inhibition.对接蛋白 p130Cas 调节细胞对蛋白酶体抑制的敏感性。
BMC Biol. 2011 Oct 28;9:73. doi: 10.1186/1741-7007-9-73.
2
Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.蛋白酶体抑制在前列腺癌细胞中诱导促细胞死亡和抗细胞死亡途径。
Cancer Lett. 2006 Nov 18;243(2):217-27. doi: 10.1016/j.canlet.2005.11.033. Epub 2006 Jan 18.
3
Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicity.静止的成纤维细胞可免受蛋白酶体抑制介导的毒性影响。
Mol Biol Cell. 2012 Sep;23(18):3566-81. doi: 10.1091/mbc.E12-03-0192. Epub 2012 Aug 8.
4
The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.谷胱甘肽 S-转移酶-甜菜碱同型半胱氨酸甲基转移酶检测揭示了哺乳动物细胞中蛋白酶体抑制诱导的巨自噬的独特机制。
Autophagy. 2015;11(5):812-32. doi: 10.1080/15548627.2015.1034402.
5
The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells.迷迭香酸的细胞毒性浓度会增加MG132诱导的HepG2细胞的细胞毒性、蛋白酶体抑制、自噬、细胞应激和凋亡。
Hum Exp Toxicol. 2020 Apr;39(4):514-523. doi: 10.1177/0960327119896614. Epub 2019 Dec 26.
6
v-Crk induces Rac-dependent membrane ruffling and cell migration in CAS-deficient embryonic fibroblasts.v-Crk在缺乏CAS的胚胎成纤维细胞中诱导Rac依赖性的膜皱襞形成和细胞迁移。
Mol Cells. 2008 Feb 29;25(1):131-7.
7
The docking protein HEF1 is an apoptotic mediator at focal adhesion sites.对接蛋白HEF1是粘着斑位点处的一种凋亡介质。
Mol Cell Biol. 2000 Jul;20(14):5184-95. doi: 10.1128/MCB.20.14.5184-5195.2000.
8
Proteasome and p62/SQSTM1 are involved in methylmercury toxicity mitigation in mouse embryonic fibroblast cells.蛋白酶体和 p62/SQSTM1 参与了甲基汞毒性在小鼠胚胎成纤维细胞中的缓解。
J Toxicol Sci. 2023;48(6):355-361. doi: 10.2131/jts.48.355.
9
p62/SQSTM1 is involved in caspase-8 associated cell death induced by proteasome inhibitor MG132 in U87MG cells.p62/SQSTM1参与蛋白酶体抑制剂MG132在U87MG细胞中诱导的与半胱天冬酶-8相关的细胞死亡。
Cell Biol Int. 2014 Oct;38(10):1221-6. doi: 10.1002/cbin.10311. Epub 2014 May 19.
10
BAG3-dependent noncanonical autophagy induced by proteasome inhibition in HepG2 cells.蛋白酶体抑制剂诱导 HepG2 细胞中依赖 BAG3 的非典型自噬。
Autophagy. 2013 Jun 1;9(6):905-16. doi: 10.4161/auto.24292. Epub 2013 Apr 10.

引用本文的文献

1
Autophagy as a Guardian of Vascular Niche Homeostasis.自噬作为血管壁龛稳态的守护者。
Int J Mol Sci. 2024 Sep 20;25(18):10097. doi: 10.3390/ijms251810097.
2
Cell adhesion suppresses autophagy via Src/FAK-mediated phosphorylation and inhibition of AMPK.细胞黏附通过Src/FAK 介导的磷酸化和 AMPK 的抑制来抑制自噬。
Cell Signal. 2022 Jan;89:110170. doi: 10.1016/j.cellsig.2021.110170. Epub 2021 Oct 18.
3
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.p130Cas支架蛋白通过改变乳腺癌细胞对自噬的敏感性来调节ErbB2的稳定性。

本文引用的文献

1
A continuum model for tumour suppression.肿瘤抑制的连续统模型。
Nature. 2011 Aug 10;476(7359):163-9. doi: 10.1038/nature10275.
2
Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways.BH3 仅蛋白的选择性参与和 Noxa 在不同凋亡途径中的不同靶标。
Cell Death Differ. 2011 May;18(5):864-73. doi: 10.1038/cdd.2010.152. Epub 2010 Nov 26.
3
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation.蛋白酶体抑制剂 PS-341(硼替佐米)诱导钙蛋白酶依赖的 IκBα降解。
Oncotarget. 2016 Jan 26;7(4):4442-53. doi: 10.18632/oncotarget.6710.
4
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.靶向和非靶向化疗药物的不良反应,重点是超敏反应和侵袭性转移转变。
Cancer Metastasis Rev. 2013 Dec;32(3-4):723-61. doi: 10.1007/s10555-013-9447-3.
5
Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer.乳腺癌中的泛素和泛素样蛋白连接酶(E2s)。
Mol Biol Rep. 2013 Feb;40(2):2019-34. doi: 10.1007/s11033-012-2261-0. Epub 2012 Nov 28.
6
Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.上皮间质转化在子宫恶性混合 Müllerian 肿瘤发病机制中的作用:泛素蛋白酶体系统的作用和治疗机会。
Clin Transl Oncol. 2012 Apr;14(4):243-53. doi: 10.1007/s12094-012-0792-4.
7
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas.蛋白酶体抑制、新癌症疗法的探索和衔接分子 p130Cas。
BMC Biol. 2011 Oct 28;9:72. doi: 10.1186/1741-7007-9-72.
J Biol Chem. 2010 May 21;285(21):16096-104. doi: 10.1074/jbc.M109.072694. Epub 2010 Mar 24.
4
Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells.硼替佐米降低 Rb 磷酸化并诱导伊马替尼敏感和耐药 Bcr-Abl1 表达细胞中的 caspase 依赖性凋亡。
Oncogene. 2010 Jun 3;29(22):3276-86. doi: 10.1038/onc.2010.81. Epub 2010 Mar 22.
5
The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack.蛋白酶体抑制剂硼替佐米可增强黑色素瘤细胞对过继 CTL 攻击的敏感性。
Cancer Res. 2010 Mar 1;70(5):1825-34. doi: 10.1158/0008-5472.CAN-09-3175. Epub 2010 Feb 23.
6
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.硼替佐米上调激活的信号转导子和转录激活子 3 并与信号转导子和转录激活子 3 的抑制剂协同作用,促进头颈部鳞状细胞癌细胞死亡。
Mol Cancer Ther. 2009 Aug;8(8):2211-20. doi: 10.1158/1535-7163.MCT-09-0327. Epub 2009 Jul 28.
7
A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.人乳腺癌细胞中p130Cas与化疗药物阿霉素耐药性之间的一种新关联。
Cancer Res. 2008 Nov 1;68(21):8796-804. doi: 10.1158/0008-5472.CAN-08-2426.
8
Extracellular matrix regulation of autophagy.细胞外基质对自噬的调节
Curr Opin Cell Biol. 2008 Oct;20(5):583-8. doi: 10.1016/j.ceb.2008.05.002. Epub 2008 Jun 21.
9
Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.硼替佐米(万珂)通过降解结直肠癌中的S期激酶相关蛋白2来诱导p27Kip1表达。
Cancer Res. 2008 May 1;68(9):3379-88. doi: 10.1158/0008-5472.CAN-07-6109.
10
FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells.FIP200是一种与ULK相互作用的蛋白质,是哺乳动物细胞中自噬体形成所必需的。
J Cell Biol. 2008 May 5;181(3):497-510. doi: 10.1083/jcb.200712064. Epub 2008 Apr 28.